文献速递心境障碍会诊联络精神医学

能量稳态在抑郁症病理生理及其异质性中的作用

The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

本研究利用大规模全基因组关联研究汇总数据和两个前瞻性精神病学队列(CoLaus|PsyCoLaus 与 NESDA),检验代谢、内感受和动机通路共享遗传易感性是否与特定抑郁症状表达相关。结果发现,能量稳态相关潜在因子的多基因评分在伴有食欲增加和嗜睡的抑郁症患者中显著更高,提示抑郁症存在以能量稳态改变为特征的病理生理模块。

要点

  • 能量稳态相关多基因评分在伴食欲增加的抑郁症患者中显著升高。
  • 该多基因评分在伴嗜睡的抑郁症患者中亦显著升高。
  • 上述关联在对照比较和与其他抑郁症患者比较中均显著。

核心结论

  • 研究识别出一个以能量稳态改变为特征的抑郁症病理生理模块,与反映能量节省和摄入反应的特定症状相关。
  • 这些发现可用于识别代谢风险较高的抑郁症患者,并可能为开发靶向治疗铺路。

研究设计与样本

  • 研究使用大规模全基因组关联研究的汇总数据以及两个前瞻性精神病学队列的个体数据。
  • 队列包括 CoLaus|PsyCoLaus(基于人群)和 NESDA(临床富集)队列。
  • CoLaus|PsyCoLaus 样本含 1407 例 MDD 患者和 2020 名对照;NESDA 样本含 1803 例 MDD 患者和 266 名对照。
  • MDD 终身诊断通过半结构化诊断访谈确定。
  • 数据分析时间为 2023 年 5 月至 2024 年 11 月。

主要发现

  • 多向孟德尔随机化估计和遗传相关性(r = 0.11-0.81)表明所选特质间存在共享遗传基础。
  • 通过基因组结构方程模型将共享遗传基础建模为潜在稳态因子。
  • 在队列数据中,潜在稳态因子的 PGS 在伴食欲增加的 MDD 患者中显著高于对照(OR 2.25,95% CI 2.00-2.53;P = 9.03 × 10-41)。
  • 该 PGS 在伴食欲增加的 MDD 患者中亦显著高于其他 MDD 患者(OR 1.88,95% CI 1.63-2.18;P = 2.38 × 10-17)。
  • 该 PGS 在伴嗜睡的 MDD 患者中显著高于对照(OR 1.22,95% CI 1.10-1.35;P = 1.15 × 10-04)和其他 MDD 患者(OR 1.18,95% CI 1.05-1.33;P = 5.80 × 10-03)。

关键数值与推荐

  • 共分析 15 项抑郁症状。
  • PGS 关联显著性以错误发现率 <5% 为标准。
  • 伴食欲增加的 MDD 患者与对照比较:OR 2.25(95% CI 2.00-2.53),P = 9.03 × 10-41。
  • 伴嗜睡的 MDD 患者与对照比较:OR 1.22(95% CI 1.10-1.35),P = 1.15 × 10-04。
  • 伴食欲增加的 MDD 患者与其他 MDD 患者比较:OR 1.88(95% CI 1.63-2.18),P = 2.38 × 10-17。

临床怎么用

  • 可依据能量稳态相关多基因评分识别代谢风险较高的抑郁症患者。
  • 对伴有食欲增加和嗜睡症状的抑郁症患者,应关注其代谢健康风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Energy homeostatic dysregulation may constitute 1 module of the heterogeneous pathophysiology of major depressive disorder (MDD), potentially manifesting as a distinctive symptom profile. OBJECTIVE: To test whether the shared genetic liability of metabolic, interoceptive, and motivational pathways involved in energy homeostasis regulation is associated with the expression of specific MDD symptoms. DESIGN, SETTING, AND PARTICIPANTS: This study used summary-level data from large genome-wide association studies and individual-level data from 2 prospective psychiatric cohorts, the CoLaus|PsyCoLaus (population-based) and Netherlands Study of Depression and Anxiety (NESDA; clinically enriched) cohorts. Data were retrieved and analyzed from May 2023 through November 2024. A lifetime diagnosis of MDD was ascertained with semistructured diagnostic interviews. The sample comprised 1407 MDD cases and 2020 controls from CoLaus|PsyCoLaus and 1803 MDD cases and 266 controls from NESDA. EXPOSURES: Genomic structural equation modeling was applied to model a unique underlying factor capturing the common genetic liability shared among metabolic and interoceptive signals (body mass index, triglycerides, fasting glucose, C-reactive protein, leptin) and motivational (anhedonia) processes. From this underlying factor, a polygenic score (PGS) was derived, indexing the shared genetic liability of traits potentially involved in energy homeostasis regulation. MAIN OUTCOMES AND MEASURES: A total of 15 depressive symptoms endorsed by participants during MDD. RESULTS: Among 1407 MDD cases (66.2% female; median year of birth [YOB], 1956) and 2020 controls (44.3% female; median YOB, 1955) from CoLaus|PsyCoLaus and 1803 MDD cases (68.3% female; median YOB, 1962) and 266 controls (56.0% female; median YOB, 1960) from NESDA, multiple significant bidirectional mendelian randomization estimates and genetic correlations (r = 0.11-0.81) indicated a shared genetic basis between the selected traits, which was modeled as a latent homeostatic factor with genomic structural equation modeling. In cohort data, the PGS indexing the latent homeostatic factor was significantly (false discovery rate, <5%) higher in MDD cases endorsing appetite increase and hypersomnia when contrasted with both controls (appetite increase odds ratio [OR], 2.25 [95% CI, 2.00-2.53]; P = 9.03 × 10-41; hypersomnia OR, 1.22 [95% CI, 1.10-1.35]; P = 1.15 × 10-04) and other MDD cases (appetite increase OR, 1.88 [95% CI, 1.63-2.18]; P = 2.38 × 10-17; hypersomnia OR, 1.18 [95% CI, 1.05-1.33]; P = 5.80 × 10-03). CONCLUSIONS AND RELEVANCE: This study identified a module of depression pathophysiology characterized by altered energy homeostasis and associated with the expression of specific symptoms reflecting energy saving and intake responses. These findings could be used to identify patients with depression at higher metabolic risk and could pave the way for the development of targeted treatments.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Pistis G, Strippoli MF, van Dalfsen JH, et al. The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity. JAMA Psychiatry. 2025. PMID: 40768164. doi:10.1001/jamapsychiatry.2025.1858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。